Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04QRG
|
|||
| Former ID |
DIB003642
|
|||
| Drug Name |
Antineoplaston A-10
|
|||
| Synonyms |
Atengenal; Antineoplaston A-10, Burzynski Institute
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] | Phase 2 | [1] | |
| Company |
Burzynski research institute
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H14N2O3
|
|||
| Canonical SMILES |
C1CC(=O)NC(=O)C1NC(=O)CC2=CC=CC=C2
|
|||
| InChI |
1S/C13H14N2O3/c16-11-7-6-10(13(18)15-11)14-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,17)(H,15,16,18)/t10-/m0/s1
|
|||
| InChIKey |
OQGRFQCUGLKSAV-JTQLQIEISA-N
|
|||
| CAS Number |
CAS 91531-30-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report. Drugs R D. 2004;5(6):315-26. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.